Targeting the YXXΦ Motifs of the SARS Coronaviruses 1 and 2 ORF3a Peptides by In Silico Analysis to Predict Novel Virus-Host Interactions
Overview
Molecular Biology
Authors
Affiliations
The emerging SARS-CoV and SARS-CoV-2 belong to the family of "common cold" RNA coronaviruses, and they are responsible for the 2003 epidemic and the current pandemic with over 6.3 M deaths worldwide. The ORF3a gene is conserved in both viruses and codes for the accessory protein ORF3a, with unclear functions, possibly related to viral virulence and pathogenesis. The tyrosine-based YXXΦ motif (Φ: bulky hydrophobic residue-L/I/M/V/F) was originally discovered to mediate clathrin-dependent endocytosis of membrane-spanning proteins. Many viruses employ the YXXΦ motif to achieve efficient receptor-guided internalisation in host cells, maintain the structural integrity of their capsids and enhance viral replication. Importantly, this motif has been recently identified on the ORF3a proteins of SARS-CoV and SARS-CoV-2. Given that the ORF3a aa sequence is not fully conserved between the two SARS viruses, we aimed to map in silico structural differences and putative sequence-driven alterations of regulatory elements within and adjacently to the YXXΦ motifs that could predict variations in ORF3a functions. Using robust bioinformatics tools, we investigated the presence of relevant post-translational modifications and the YXXΦ motif involvement in protein-protein interactions. Our study suggests that the predicted YXXΦ-related features may confer specific-yet to be discovered-functions to ORF3a proteins, significant to the new virus and related to enhanced propagation, host immune regulation and virulence.
Zhang J, Hom K, Zhang C, Nasr M, Gerzanich V, Zhang Y Pathogens. 2024; 13(1).
PMID: 38251382 PMC: 10819734. DOI: 10.3390/pathogens13010075.
Zhang J, Cruz-Cosme R, Zhang C, Liu D, Tang Q, Zhao R mBio. 2023; 15(1):e0303023.
PMID: 38078754 PMC: 10790703. DOI: 10.1128/mbio.03030-23.
Noor F, Ashfaq U, Asif M, Adeel M, Alshammari A, Alharbi M Front Immunol. 2022; 13:1031608.
PMID: 36275660 PMC: 9584616. DOI: 10.3389/fimmu.2022.1031608.